Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor responses across multiple cancer models.AsyliaTherapeutics was founded in 2019 in Houston, Texas.

Biotechnology

Health Care

Therapeutics

Asylia Therapeutics, Inc.

Asylia Therapeutics, Inc.'s headquarters in Houston, TX, United States

Description

People (3)

Richard Jones, Ph.D.

John Miller

Parth Mangrolia, PhD

Jobs